MedTrace Logo

Responsiveness and MID of 4 Metre Gait Speed in Idiopathic Pulmonary Fibrosis

NCT02530736 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2017-11-09

No results posted yet for this study

Summary

This study measures the 4 metre gait speed (4MGS) test in patients with Idiopathic Pulmonary Fibrosis (IPF). The investigators are interested to see whether usual walking speed in IPF patients changes following pulmonary rehabilitation and if it changes, what is the smallest change that is meaningful to patients.

Conditions

Interventions

OTHER

4 metre gait speed

Measurement of usual walking speed over 4 metres. Change in walking speed is measured at baseline (pre-pulmonary rehabilitation assessment) and 8 weeks later (post-pulmonary rehabilitation assessment)

Sponsors & Collaborators

  • National Institute for Health Research, United Kingdom

    collaborator OTHER_GOV

  • Royal Brompton & Harefield NHS Foundation Trust

    lead OTHER

Principal Investigators

  • William DC Man, MD, PhD · Royal Brompton and Harefield NHS Foundation Trust

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2016-10-17
Completion
2017-10-18

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02530736 on ClinicalTrials.gov